MedPath

Proactive versus reactive inhibition in ADHD

Phase 1
Conditions
Attention-Deficit Hyperactivity Disorder (ADHD)
Therapeutic area: Psychiatry and Psychology [F] - Psychological processes [F02]
Registration Number
EUCTR2012-000992-18-NL
Lead Sponsor
MC Utrecht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Children diagnosed with ADHD according to DSM IV criteria
Age between 8-16
Willing to discontinue methylphenidate 48 hours before testing
IQ above 75
Are the trial subjects under 18? yes
Number of subjects for this age range: 80
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

History of or present neurological disorder
One or more of the following comorbid disorders are diagnosed: generalized anxiety disorder, depression, tics,
psychosis or autism
IQ below 75

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath